跳至主要内容
临床试验/NCT07561671
NCT07561671已完成不适用

Split-Side Comparative Clinical Study of Platelet-Rich Fibrin Versus Platelet-Rich Plasma With or Without Microneedling in Treatment of Striae Distensae

Zagazig University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年2月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
INA score (Change in striae severity)

研究概览

简要总结

A split-side comparative clinical study evaluating the efficacy and safety of injectable platelet-rich fibrin (PRF) versus platelet-rich plasma (PRP), alone or combined with microneedling, in the treatment of striae distensae. Thirty patients received PRF or PRP on one side and combination therapy with microneedling on the contralateral side over five sessions. Outcomes included striae width, length, severity score, and patient satisfaction

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults ≥18 years
  • Presence of striae distensae (rubrae or alba)
  • Willingness to participate and provide informed consent

排除标准

  • Keloid or hypertrophic scar tendency
  • Bleeding disorders or anticoagulant use
  • Pregnancy
  • Active skin infections (e.g., herpes, impetigo, tinea)
  • History of malignancy or collagen disease
  • Use of antineoplastic drugs
  • Conditions impairing wound healing
  • Unrealistic expectations

研究组 & 干预措施

PRF

Active Comparator

Intradermal injection of platelet-rich fibrin

干预措施: PRF group (Biological)

PRP

Active Comparator

Intradermal injection of platelet-rich plasma

干预措施: PRP injection (Biological)

结局指标

主要结局

INA score (Change in striae severity)

时间窗: baseline to 1 month after last session

Change in striae severity (INA score)

时间窗: 1 month after last session

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Mona El Radi Kamal Mohamed Emam

Dr

Zagazig University

研究点 (1)

Loading locations...

相似试验